Utah Med (UTMD): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Utah Medical (UTMD)

A conservative approach to quality control and personnel policy minimizes operational risks for Utah Medical Products (UTMD). The current price-to-sales ratio visualizes this stability, with 6.50 serving as the final level marker. Resilience is driven by high-margin niches in neonatology and gynecology. Long-term clinical dependence on the brand's consumables guarantees a steady cash flow, confirming the strength of the business model.

Price-to-Revenue Ratio: Utah Medical Products, Inc. (UTMD) for 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Utah Medical Products, Inc. (UTMD)

Summary company analytics:Utah Medical Products Inc.
Mass-produced product of utahmed.com

The P/S ratio determines the market value of a business relative to its actual sales volume, allowing for an assessment of the premium paid per unit of revenue. Analyzing the price-to-sales metric helps identify the fair value of Utah Medical Products (UTMD), where the high margins of specialized medical plastics and patent protection make the model scalable, ensuring operational efficiency with minimal production costs.

Competitors of Utah Medical Products

Market Cap to Sales Volume ISRG|Danaher Corporation - Market Cap to Revenue|P/S Multiple Becton Dickinson & Company BDX|STE - Price-to-Revenue Ratio|West Pharmaceutical Services (WST) - Market Cap to Revenue|BAX: P/S Multiple|Market Cap to Revenue Masimo|STVN (stevanatogroup.com) - P/S Multiple|Market Cap to Revenue Ratio TFX (Teleflex Incorporated)|Price-to-Revenue Ratio Merit Medical (MMSI)|Envista - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (Dentsply Sirona Inc)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Corp ATRC|staar.com (STAA) - Price-to-Revenue Ratio|Market Cap to Revenue ChromaDex Corporation|ZIMV (ZimVie Inc) - P/S Multiple|Market Cap to Revenue Ratio ANGO (AngioDynamics)|Price-to-Revenue Ratio Cerus Corp (CERS)|TKNO: Price-to-Sales Ratio|Price-to-Revenue Ratio Monogram Technologies Inc. MGRM|Market Capitalization-to-Revenue Ratio STSS|INFU - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio KRMD (KORU Medical)|NYXH: P/S Multiple|MBOT (Microbot Medical, Inc) - Price-to-Revenue Ratio|Market Cap to Revenue PDEX|ZTEK: Market Capitalization-to-Revenue Ratio|P/S Multiple ELUT|Milestone Scientific Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NEXGEL, Inc. NXGL|Retractable Tech - Price-to-Revenue Ratio|harvardbioscience.com - P/S Multiple|FEMY (Femasys Inc.) - Market Cap to Revenue Ratio|MHUA: P/S Multiple|Predictive Oncology Corp - Market Capitalization-to-Revenue Ratio|CJMB (Callan JMB) - P/S Multiple|Price to Sales Atrion Corporation Inc. ATRI|P/S Multiple NURO